ORASURE TECHNOLOGIES, INC (OSUR) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $0.00; Additional Paid in Capital, Common StockUSD $527.96M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-21.90M.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $0.00; Additional Paid in Capital, Common StockUSD $527.90M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-20.04M.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $0.00; Additional Paid in Capital, Common StockUSD $531.39M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-18.40M.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $0.00; Additional Paid in Capital, Common StockUSD $535.03M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-20.17M.
ORASURE TECHNOLOGIES, INC Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Treasury Stock, Value, Acquired, Cost Method USD | Treasury Stock, Retired, Cost Method, Amount USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Treasury Stock, Shares, Acquired shares | Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax USD | AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax USD | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition USD | APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $0.00 | $527.96M | $-21.90M | $-188.29M | $317.78M | (m) | 3 month · $2.00M | 3 month · $2.29M | 3 month · 600.00K 6 month · 2.40M | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $0.00 | $0.00 | $527.90M | $-20.04M | $-194.54M | $313.32M | (m) | 3 month · $5.00M | 3 month · $2.77M | 3 month · 1.80M | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | $0.00 | $531.39M | $-18.40M | $-172.16M | $340.83M | (m) | 12 month · $15.04M | 12 month · $10.15M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $0.00 | $0.00 | $535.03M | $-20.17M | $-152.88M | $361.98M | 3 month · $5.00M | (m) | 3 month · $2.83M | 3 month · 1.52M 9 month · 3.30M | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $0.00 | $0.00 | $537.26M | $-17.37M | $-139.16M | $380.72M | 3 month · $5.00M | 3 month · $5.00M | 3 month · $3.17M | 3 month · 1.80M 6 month · 1.80M | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $0.00 | $0.00 | $539.88M | $-24.12M | $-119.47M | $396.28M | (m) | (m) | 3 month · $2.69M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | $0.00 | $538.13M | $-24.36M | $-103.43M | $410.34M | (m) | (m) | 12 month · $11.92M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $0.00 | $0.00 | $535.40M | $-17.20M | $-92.64M | $425.56M | (m) | (m) | 3 month · $2.89M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $0.00 | $0.00 | $532.60M | $-18.63M | $-88.13M | $425.84M | (m) | (m) | 3 month · $3.32M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $0.00 | $0.00 | $531.26M | $-17.50M | $-87.52M | $426.25M | (m) | (m) | 3 month · $2.97M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | $0.00 | $529.54M | $-14.94M | $-83.93M | $430.67M | (m) | (m) | 12 month · $10.73M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $0.00 | $0.00 | $526.26M | $-17.37M | $-104.00M | $404.88M | (m) | (m) | 3 month · $2.59M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $0.00 | $0.00 | $523.86M | $-14.56M | $-115.16M | $394.14M | (m) | (m) | 3 month · $2.36M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $0.00 | $521.96M | $-17.42M | $-110.37M | $394.18M | (m) | (m) | 3 month · $2.65M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $0.00 | $0.00 | $520.45M | $-18.43M | $-137.59M | $364.43M | (m) | (m) | 12 month · $11.62M | (m) | $18.21M | $220.00K | (m) | (m) | (m) |
| 2022-09-30 | (m) | $0.00 | $518.17M | $-22.33M | $-153.95M | $342.45M | (m) | (m) | 3 month · $2.30M | (m) | $22.06M | $267.00K | (m) | (m) | (m) |
| 2022-06-30 | (m) | $0.00 | $515.93M | $-12.51M | $-159.22M | $344.43M | (m) | (m) | 3 month · $3.28M | (m) | $12.24M | $278.00K | (m) | (m) | (m) |
| 2022-03-31 | (m) | $0.00 | $513.55M | $-8.25M | $-140.42M | $364.91M | (m) | (m) | 3 month · $2.65M | (m) | $7.89M | $359.00K | (m) | (m) | (m) |
| 2021-12-31 | (m) | $0.00 | $511.06M | $-10.08M | $-120.45M | $380.53M | (m) | (m) | 12 month · $7.81M | (m) | $9.64M | $434.00K | (m) | (m) | (m) |
| 2021-09-30 | (m) | $0.00 | $508.60M | $-10.72M | $-110.06M | $387.82M | (m) | (m) | 3 month · $2.22M | (m) | $10.11M | $610.00K | (m) | (m) | (m) |
| 2021-06-30 | (m) | $0.00 | $506.30M | $-6.44M | $-95.05M | $404.82M | (m) | (m) | 3 month · $1.47M | (m) | $5.99M | $449.00K | (m) | (m) | (m) |
| 2021-03-31 | (m) | $0.00 | $504.95M | $-7.72M | $-93.68M | $403.54M | (m) | (m) | 3 month · $1.46M | (m) | $7.40M | $327.00K | (m) | (m) | (m) |
| 2020-12-31 | (m) | $0.00 | $505.12M | $-9.10M | $-97.45M | $398.57M | (m) | (m) | 12 month · $7.14M | (m) | $8.75M | $348.00K | (m) | (m) | (m) |
| 2020-09-30 | (m) | $0.00 | $502.80M | $-15.60M | $-99.31M | $387.89M | (m) | (m) | 3 month · $1.86M | (m) | $15.56M | $31.00K | (m) | (m) | (m) |
| 2020-06-30 | (m) | $0.00 | $499.39M | $-17.28M | $-100.36M | $381.76M | (m) | (m) | 3 month · $2.67M | (m) | $17.52M | $235.00K | (m) | (m) | (m) |
| 2020-03-31 | (m) | $0.00 | $401.81M | $-21.80M | $-89.86M | $290.15M | (m) | (m) | 3 month · $1.38M | (m) | $21.24M | $556.00K | (m) | (m) | (m) |
| 2019-12-31 | (m) | $0.00 | $401.81M | $-12.14M | $-82.53M | $307.14M | (m) | (m) | 12 month · $4.06M | (m) | $12.02M | $114.00K | 12 month · $1.16M | 12 month · $2.98M | 12 month · $-83.00K |
| 2019-09-30 | (m) | $0.00 | $401.01M | $-14.68M | $-84.97M | $301.37M | (m) | (m) | 3 month · $1.44M | (m) | $14.64M | $40.00K | 3 month · $259.00K | 3 month · $858.00K | 3 month · $319.00K |
| 2019-06-30 | (m) | $0.00 | $399.58M | $-13.31M | $-98.05M | $288.22M | (m) | (m) | 3 month · $616.00K | (m) | $13.08M | $234.00K | 3 month · $311.00K | 3 month · $874.00K | 3 month · $-569.00K |
| 2019-03-31 | (m) | $0.00 | $398.93M | $-15.98M | $-102.45M | $280.51M | (m) | (m) | 3 month · $1.23M | (m) | $15.56M | $421.00K | 3 month · $324.00K | 3 month · $653.00K | 3 month · $254.00K |
| 2018-12-31 | (m) | $0.00 | $401.27M | $-18.71M | $-99.19M | $283.38M | (m) | (m) | 12 month · $15.24M | (m) | $17.79M | $917.00K | 12 month · $2.16M | 12 month · $6.36M | 12 month · $6.72M |
| 2018-09-30 | (m) | $0.00 | $398.96M | $-12.71M | $-109.49M | $276.75M | (m) | (m) | (m) | (m) | $11.81M | $905.00K | 3 month · $359.00K | 3 month · $589.00K | 3 month · $316.00K |
| 2018-06-30 | (m) | $0.00 | $397.22M | $-14.46M | $-117.58M | $265.17M | (m) | (m) | (m) | (m) | $13.59M | $871.00K | 3 month · $475.00K | 3 month · $1.42M | 3 month · $1.89M |
| 2018-03-31 | (m) | $0.00 | $393.43M | $-13.01M | $-121.70M | $258.72M | (m) | (m) | (m) | (m) | $11.94M | $1.06M | 3 month · $900.00K | 3 month · $3.63M | 3 month · $2.96M |
| 2017-12-31 | (m) | $0.00 | $387.93M | $-10.34M | $-119.51M | $258.08M | (m) | (m) | (m) | (m) | $9.79M | $553.00K | 12 month · $2.04M | 12 month · $2.71M | 12 month · $2.22M |
| 2017-09-30 | (m) | $0.00 | $385.98M | $-9.64M | $-126.83M | $249.51M | (m) | (m) | (m) | (m) | $9.34M | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | $0.00 | $373.96M | $-11.96M | $-132.59M | $229.41M | (m) | (m) | (m) | (m) | $2.31M | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | $0.00 | $360.61M | $-13.77M | $-138.02M | $208.82M | (m) | (m) | (m) | (m) | $450.00K | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | $0.00 | $350.53M | $-14.22M | $-150.46M | $185.85M | (m) | (m) | (m) | (m) | $14.22M | (m) | 12 month · $2.69M | 12 month · $2.86M | 12 month · $511.00K |
| 2016-09-30 | (m) | $0.00 | $347.27M | $-13.14M | $-157.65M | $176.48M | (m) | (m) | (m) | (m) | $2.50M | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | $0.00 | $345.09M | $-12.41M | $-163.90M | $168.79M | (m) | (m) | (m) | (m) | $3.23M | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | $0.00 | $343.52M | $-12.77M | $-167.73M | $163.01M | (m) | (m) | (m) | (m) | $2.87M | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | $0.00 | $345.25M | $-15.64M | $-170.18M | $159.44M | (m) | (m) | (m) | (m) | $-7.79M | (m) | 12 month · $3.40M | 12 month · $2.64M | (m) |
| 2015-09-30 | (m) | $0.00 | $348.68M | $-13.88M | $-174.79M | $160.00M | (m) | (m) | (m) | (m) | $-6.04M | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | $0.00 | $347.14M | $-11.03M | $-176.26M | $159.85M | (m) | (m) | (m) | (m) | $-3.18M | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | $0.00 | $345.72M | $-11.66M | $-178.23M | $155.83M | (m) | (m) | (m) | (m) | $-3.81M | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | $0.00 | $344.89M | $-7.85M | $-178.34M | $158.70M | (m) | 12 month · $639.00K | (m) | (m) | $-4.05M | (m) | 12 month · $3.08M | 12 month · $2.66M | (m) |
| 2014-09-30 | (m) | (m) | $342.87M | $-6.25M | $-175.69M | $160.92M | (m) | (m) | (m) | (m) | $2.45M | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | $341.11M | $-3.95M | $-176.83M | $160.32M | (m) | (m) | (m) | (m) | $156.00K | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | $339.65M | $-5.58M | $-179.36M | $154.71M | (m) | (m) | (m) | (m) | $1.78M | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | $0.00 | $338.67M | $-3.80M | $-173.73M | $161.15M | (m) | 12 month · $829.00K | (m) | (m) | $-3.13M | (m) | 12 month · $2.69M 12 month · $2.69M | 12 month · $2.88M 12 month · $2.88M | (m) |
| 2013-09-30 | (m) | (m) | $337.21M | $-2.38M | $-179.94M | $154.89M | (m) | (m) | (m) | (m) | $1.71M | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | $335.86M | $-3.25M | $-178.05M | $154.55M | (m) | (m) | (m) | (m) | $-2.58M | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | $334.48M | $-1.79M | $-172.77M | $159.92M | (m) | (m) | (m) | (m) | $1.12M | (m) | (m) | (m) | (m) |
| 2013-01-01 | (m) | (m) | (m) | (m) | (m) | $170.31M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | $333.52M | $-666.00K | $-162.54M | $170.31M | (m) | 12 month · $1.56M | (m) | (m) | $1.30M | (m) | 12 month · $2.26M | 12 month · $2.89M | (m) |
| 2012-09-30 | (m) | $55.00 | $331.69M | $-232.20K | $-156.68M | $174.78M | (m) | (m) | (m) | (m) | $1.73M | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | $48.00 | $254.80M | $-1.72M | $-154.24M | $98.84M | (m) | (m) | (m) | (m) | $246.00K | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | $48.00 | $251.83M | $-858.66K | $-150.68M | $100.29M | (m) | (m) | (m) | (m) | $1.11M | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | $47.00 | $249.64M | $-1.96M | $-147.43M | $100.25M | (m) | 12 month · $909.00K | (m) | (m) | $-1.73M | (m) | 12 month · $1.58M | 12 month · $2.52M | (m) |
| 2011-09-30 | (m) | $47.00 | $246.58M | $-3.07M | $-147.54M | $95.97M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | $47.00 | $245.06M | $-233.83K | $-143.62M | $101.20M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $46.00 | $241.66M | $-235.26K | $-138.59M | $102.84M | (m) | 12 month · $709.00K | (m) | (m) | (m) | (m) | 12 month · $884.00K | 12 month · $2.35M | (m) |
| 2009-12-31 | (m) | (m) | (m) | (m) | (m) | $103.81M | (m) | 12 month · $391.59K | (m) | (m) | (m) | (m) | 12 month · $1.32M | 12 month · $2.62M | (m) |
| 2008-12-31 | (m) | (m) | (m) | (m) | (m) | $108.33M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |